Infectious Disease News Articles

▼ Show details

The latest Infectious Disease news articles, summarized and published daily to keep you current in today's news on bacterial infection, disease treatments, HIV/AIDS, hepatitis and clinical research in infectious diseases and more.

New! >> Start your free Infectious Disease Board Exam Prep course now.
Ranked, sorted, and summarized by MDLinx editors from the latest literature

1 Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: An individual patient data meta-analysis Clinical Infectious Diseases, September 15, 2014    Evidence Based Medicine    Clinical Article

2 Caesarean section to prevent transmission of hepatitis B: A meta-analysis Canadian Journal of Gastroenterology, September 15, 2014    Evidence Based Medicine

3 Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks Hepatology International, September 15, 2014    Evidence Based Medicine

4 Cirrhosis regression in patients with viral hepatitis B and C: A systematic review Journal of Clinical Gastroenterology, September 15, 2014    Review Article

5 Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy The Journal of Infectious Diseases, September 15, 2014    Clinical Article

6 Rarely seen infections Clinics in Dermatology, September 15, 2014    Clinical Article

7 Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial Full Text Trials, September 15, 2014    Evidence Based Medicine    Clinical Article

8 Effects of ezetimibe on cholesterol metabolism in HIV-infected patients with protease inhibitor-associated dyslipidemia: A single-arm intervention trial Full Text BMC Infectious Diseases, September 15, 2014    Clinical Article

9 Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using fibroscan: Validation in chronic hepatitis B Digestive Diseases and Sciences, September 15, 2014    Clinical Article

10 Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapy Journal of Acquired Immune Deficiency Syndromes, September 15, 2014    Clinical Article

11 Heterologous immunological effects of early BCG vaccination in low-birth weight infants in Guinea-Bissau: A randomized-controlled trial The Journal of Infectious Diseases, September 15, 2014    Clinical Article

12 A prolonged second diagnostic window for human immunodeficiency virus (HIV-1) type 1 in a fourth generation immunoassay: Are alternative testing strategies required? Journal of Clinical Microbiology, September 15, 2014    Clinical Article

13 Emerging trends of HIV drug resistance in Chinese HIV-infected patients receiving first-line highly active antiretroviral therapy: A systematic review and meta-analysis Clinical Infectious Diseases, September 15, 2014    Evidence Based Medicine    Review Article

14 Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy International Journal of Infectious Diseases, September 15, 2014    Clinical Article

15 Predictors of skin and soft tissue infections in HIV-infected outpatients in the community-associated methicillin-resistant Staphylococcus aureus era European Journal of Clinical Microbiology & Infectious Diseases, September 15, 2014    Clinical Article

16 Efficacy, safety and patients’ satisfaction with colonoscopic-administered fecal microbiota transplantation in relapsing and refractory community- and hospital-acquired Clostridium difficile infection Canadian Journal of Gastroenterology, September 15, 2014    Clinical Article

17 The performance and clinical utility of cervical microscopy for the diagnosis of gonorrhoea in women in the era of the NAAT International Journal of STD & AIDS, September 15, 2014    Clinical Article

18 Fidaxomicin: A Novel Macrolide Antibiotic for Clostridium difficile Infection The Consultant Pharmacist, September 15, 2014    Review Article

19 Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm European Journal of Gastroenterology & Hepatology, September 15, 2014    Clinical Article

20 Field effectiveness of hepatitis A vaccine and uptake of post exposure prophylaxis following a change to the Australian guidelines Vaccine , September 15, 2014    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Infectious Disease

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Highlights in Infectious Disease

Short-term valacyclovir therapy does not reduce HIV acquisition risk in HSV-2 infected women

As reported in the Journal of Infectious Diseases, short-term treatment of HSV-2 infected, HIV non-infected women (n=30) with valacyclovir (1 g qd x 2 months) had no effect on cervical CD4+ T cells, dendritic cells, or pro-inflammatory cytokines, but increased CCR5 (HIV co-receptor) and CD69 (activation marker).

HIV viremia associated with increased risk for NHL

As reported in Modern Pathology, CDX2 expression is associated with low-grade small intestinal adenocarcinomas, decreased nodal metastases, and decreased perineural invasion, while MUC1 expression is associated with high-grade tumors, and nodular and infiltrative tumors. The CDX2+/MUC1- immunophenotype is associated with increased survival.

Pre-treatment with EPA decreases incidence of IFN-?-induced depression

As reported in Biological Psychiatry, pre-treatment of HCV-infected patients (n=162) with EPA for 2 weeks resulted in a decreased incidence of IFN-α-induced depression at 24 weeks compared to placebo (10% vs. 30%), and a delayed onset of depression (12.0 weeks vs. 5.3 weeks).

Other Topics in Infectious Disease

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More